1. Home
  2. ABCL vs FBIN Comparison

ABCL vs FBIN Comparison

Compare ABCL & FBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

N/A

Current Price

$9.66

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Logo Fortune Brands Innovations Inc.

FBIN

Fortune Brands Innovations Inc.

N/A

Current Price

$46.83

Market Cap

4.8B

ML Signal

N/A

Company Overview

Basic Information
Metric
ABCL
FBIN
Founded
2012
1988
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Products
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.8B
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
ABCL
FBIN
Price
$9.66
$46.83
Analyst Decision
Strong Buy
Buy
Analyst Count
14
20
Target Price
$18.69
★ $49.29
AVG Volume (30 Days)
2.8M
★ 2.8M
Earning Date
11-09-2026
11-03-2026
Dividend Yield
N/A
★ 2.20%
EPS Growth
★ 10.91
N/A
EPS
N/A
★ 0.43
Revenue
$75,128,000.00
★ $4,463,200,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$13.74
N/A
P/E Ratio
★ N/A
$109.93
Revenue Growth
★ 160.56
N/A
52 Week Low
$2.75
$32.34
52 Week High
$14.98
$64.84

Technical Indicators

Market Signals
Indicator
ABCL
FBIN
Relative Strength Index (RSI) 34.01 56.01
Support Level $3.45 $36.96
Resistance Level $12.91 $53.86
Average True Range (ATR) 0.84 2.15
MACD -0.22 -0.30
Stochastic Oscillator 2.41 30.15

Price Performance

Historical Comparison
ABCL
FBIN

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About FBIN Fortune Brands Innovations Inc.

Fortune Brands is a US-based homebuilding products company that sells building-related products serving R&R and new construction markets. The company operates in three segments: water, outdoors, and security. Water innovation, including plumbing fixtures and faucets, accounts for around 55% of total sales and features brands such as Moen, House of Rohl, and Aqualisa. The outdoors segment includes decking, railing, and doors and makes up 30% of total sales, featuring brands such as Larson, Fiberon, and Therma-Tru. The security segment, which includes smart residential padlocks, accounts for the remaining 15% of sales and features brands such as MasterLock, SentrySafe, Yale, and AmericanLock.

Share on Social Networks: